Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram Presents at Morgan Stanley 17th Annual Global Healthcare Conference (Transcript) [Seeking Alpha]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Seeking Alpha
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram Presents at Morgan Stanley 17th Annual Global Healthcare Conference (Transcript) Sarepta Therapeutics, Inc. (NASDAQ: SRPT Company Participants Douglas Ingram - President and Chief Executive Officer Conference Call Participants Matthew Harrison - Morgan Stanley We’re going to get started with the next session. I’m Matthew Harrison, one of the biotech analyst here at Morgan Stanley, and pleased to have Sarepta. Just quickly before I get started, I just need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures, or you can pick up a copy at the registration desk. So very pleased to have with me Doug Ingram, who is the President and CEO of Sarepta. Doug, I don’t know if you want to make any opening comments, but if not, we’ll jump right in. Sure. Well, first, le
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- High Growth Tech Stocks To Watch For Potential Opportunities [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch In December 2024 [Yahoo! Finance]Yahoo! Finance
- High Growth Tech And 2 Other Promising Stocks With Strong Potential [Yahoo! Finance]Yahoo! Finance
- SRPT Finishes Enrolment in Late-Stage Study for Rare Muscular Disorder [Yahoo! Finance]Yahoo! Finance
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its "sell" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.MarketBeat
SRPT
Earnings
- 11/6/24 - Beat
SRPT
Sec Filings
- 12/16/24 - Form 4
- 12/12/24 - Form 144
- 12/6/24 - Form 4
- SRPT's page on the SEC website